Taiki is a serial biotech entrepreneur. Taiki is CEO & Co-founder of Logomix, a synthetic biology company developing human cells with unprecedented precision and higher-order genetic complexity for new therapeutics. Formerly, Taiki worked at JOMDD as CBO, a medtech incubator in Tokyo commercializing early-stage technologies in therapeutic and diagnostic devices. He also served as Board Director leading cancer genomics business at P5, Inc., a joint venture by Sony, Illumina, and M3 ($70B medical platform). Prior to JOMDD and P5, he worked at M3 in a variety of positions spanning new business development and post-merger integration. Prior to M3, he was a co-founder of Aqumen Biopharmaceuticals K.K., an ophthalmology biotech startup.